ALGS
Aligos Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseNov 13, 2026 3:58:40 PM EST
2.11USD+6.313%(+0.13)57,515
Pre-marketNov 13, 2026 9:27:30 AM EST
2.12USD+7.071%(+0.14)
After-hoursNov 13, 2026 4:52:30 PM EST
2.06USD-2.138%(-0.05)
ALGS Financials
In Q3 FY 2026 (ended ), Aligos Therapeutics, Inc. Common Stock (ALGS) reported revenue of $2.83M, net income of −$21.86M, operating cash flow of $1.45M, and assets of $47.19M (filed ).
Loading financial flows…